(Q80786662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Trevor Archer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Anders Fredriksson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

12 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

published in

Neurochemical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1625-1639

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694434%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11064-007-9358-1

3 January 2020

exact match

0 references

cites work

Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment

1 reference

12 December 2020

Iron-dependent enzymes in Parkinson's disease

1 reference

12 December 2020

Iron modulates neuroleptic-induced effects related to the dopaminergic system

1 reference

12 December 2020

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron

1 reference

12 December 2020

Serotonin and fear retention in the rat.

1 reference

12 December 2020

DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—A useful denervation tool for central and peripheral noradrenaline neurons

1 reference

12 December 2020

Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice

1 reference

12 December 2020

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

1 reference

12 December 2020

Increased nigral iron content in postmortem parkinsonian brain

1 reference

12 December 2020

Brain iron: a lesson from animal models.

1 reference

12 December 2020

MPTP-induced hypoactivity in mice: reversal by L-dopa

1 reference

12 December 2020

Neurobehavioural deficits following postnatal iron overload: II Instrumental learning performance

1 reference

12 December 2020

Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphine

1 reference

12 December 2020

Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice

1 reference

12 December 2020

Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin.

1 reference

12 December 2020

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

1 reference

12 December 2020

Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration

1 reference

12 December 2020

Alteration of central alpha2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin

1 reference

12 December 2020

Aging and the regulation of striatal dopaminergic mechanisms in mice.

1 reference

12 December 2020

Noradrenergic mechanisms in neurodegenerative diseases: a theory

1 reference

12 December 2020

Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases

1 reference

12 December 2020

Tolerance to behavioral effects of haloperidol

1 reference

12 December 2020

Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration

1 reference

12 December 2020

DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behavior 3 and 14 days after treatment

1 reference

12 December 2020

Clozapine: a clinical review of adverse effects and management

1 reference

12 December 2020

Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine

1 reference

12 December 2020

Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice I: dose-, time- and parameter-dependency

1 reference

12 December 2020

Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain

1 reference

12 December 2020

Nutrient deprivation and brain function: iron

1 reference

12 December 2020

Memory deficits in adult rats following postnatal iron administration

1 reference

12 December 2020

Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice.

1 reference

12 December 2020

Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.

1 reference

12 December 2020

Ontogeny of Adrenergic Arousal and Cholinergic Inhibitory Mechanisms in the Rat

1 reference

12 December 2020

On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) on the active uptake of noradrenaline

1 reference

12 December 2020

Developmental changes in transferrin and iron uptake by the brain in the rat.

1 reference

12 December 2020

Noradrenaline and dopamine interaction in rat brain during development

1 reference

12 December 2020

Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain

1 reference

12 December 2020

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition

1 reference

12 December 2020

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

1 reference

12 December 2020

Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice

1 reference

12 December 2020

Transferrin and iron uptake by the brain: effects of altered iron status

1 reference

12 December 2020

Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity

1 reference

12 December 2020

Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart

1 reference

12 December 2020

An autoradiographic study of the uptake and distribution of iron by the brain of the young rat.

1 reference

12 December 2020

Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile.

1 reference

12 December 2020

Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning

1 reference

12 December 2020

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

1 reference

12 December 2020

Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa

1 reference

12 December 2020

Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study

1 reference

12 December 2020

Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum

1 reference

12 December 2020

Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment

1 reference

12 December 2020

The possible role of iron in the etiopathology of Parkinson's disease

1 reference

12 December 2020

DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion.

1 reference

12 December 2020

T-maze learning, spontaneous activity and food intake recovery following systemic administration of the noradrenaline neurotoxin, DSP4.

1 reference

12 December 2020

Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period.

1 reference

12 December 2020

The role of transition metals in the pathogenesis of Parkinson's disease

1 reference

12 December 2020

MPTP neurotoxicity: an overview and characterization of phases of toxicity

1 reference

12 December 2020

An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice

1 reference

12 December 2020

Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions

1 reference

12 December 2020

Iron in brain function and dysfunction with emphasis on Parkinson's disease

1 reference

12 December 2020

Brain iron-deficiency causes reduced learning capacity in rats.

1 reference

12 December 2020

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease

1 reference

12 December 2020

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice

1 reference

12 December 2020

Specific effect of haloperidol on dopamine turnover in the frontal cortex

1 reference

12 December 2020

Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain

1 reference

12 December 2020

Response of central monoamine neurons following an early neurotoxic lesion

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

1 reference

12 December 2020

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

1 reference

12 December 2020

Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits.

1 reference

12 December 2020

The effect of age on the non-haemin iron in the human brain.

1 reference

12 December 2020

Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity

1 reference

12 December 2020

Hallervorden-Spatz Syndrome and Brain Iron Metabolism

1 reference

12 December 2020

Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.

1 reference

12 December 2020

MPTP-induced behavioural and biochemical deficits: a parametric analysis

1 reference

12 December 2020

Effects of alpha-adrenoceptor agonists in chronic morphine administered DSP4-treated rats: evidence for functional cross-sensitization

1 reference

12 December 2020

Functional deficits following neonatal dopamine depletion and Isolation housing: Circular water maze acquisition under pre-exposure conditions and motor activity

1 reference

12 December 2020

Magnetic resonance imaging in parkinsonism

1 reference

12 December 2020

Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion

1 reference

12 December 2020

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Noradrenergic-serotonergic interactions and nociception in the rat

1 reference

12 December 2020

Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice

1 reference

12 December 2020

Free radicals in brain metabolism and pathology

1 reference

12 December 2020

Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists

1 reference

12 December 2020

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

12 December 2020

Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists

1 reference

12 December 2020

Quantification of dopaminergic supersensitization using apomorphine-induced behavior in the mouse

1 reference

12 December 2020

Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects

1 reference

12 December 2020

Influence of noradrenaline denervation on MPTP-induced deficits in mice

1 reference

12 December 2020

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

12 December 2020

A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat.

1 reference

12 December 2020

Maximizing clozapine therapy: managing side effects

1 reference

12 December 2020

Iron, brain ageing and neurodegenerative disorders

1 reference

12 December 2020

Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents

1 reference

12 December 2020

The Pivotal Role of Iron in NF-kappaB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators

1 reference

12 December 2020